Available Positions

Exploiting ferroptosis vulnerability for TNBC therapy

Area: 
Life Sciences
Tuesday, June 1, 2021

 

Triple negative breast cancer (TNBC) is a highly aggressive breast cancer subtype that currently has no effective targeted therapy. We have recently found that TNBCs are particular susceptible to ferroptotic cell death. Ferroptosis is a newly discovered cell death pathway driven by iron-dependent lipid peroxidation. We established multidisciplinary projects related to ferroptosis in TNBC, and are currently looking for a motivated and enthusiastic PhD student to join us.